Direxion Daily S&P Biotech Bull 3X ETF (LABU)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 222.94 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 0.96% |
| Assets under management | 561.9M USD |
| Net asset value per share | 210.11 USD |
| Inception | May 28, 2015 |
| Sponsor | Direxion |
| Asset class | Leveraged/Inverse |
| Holdings the fund reports | 156 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 25 by weight of the 173 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | SPSIBI SWAP ASSET LEG (SPSIBIUBL) (not a company) | 52.55% |
| 2 | SPSIBI SWAP ASSET LEG (SPSIBIMLL) (not a company) | 47.86% |
| 3 | SPSIBI SWAP ASSET LEG (SPSIBICTL) (not a company) | 40.92% |
| 4 | SPSIBI SWAP ASSET LEG (SPSIBIBCL) (not a company) | 38.00% |
| 5 | SPSIBI SWAP ASSET LEG (SPSIBIJPL) (not a company) | 32.21% |
| 6 | GOLDMAN FINL SQ TRSRY INST 506 | 24.39% |
| 7 | SPSIBI SWAP ASSET LEG (SPSIBIBPL) (not a company) | 4.35% |
| 8 | DREYFUS GOVT CASH MAN INS (a fund) | 2.96% |
| 9 | SPSIBI SWAP ASSET LEG (SPSIBIGSL) (not a company) | 2.84% |
| 10 | MODERNA INC | 2.00% |
| 11 | TWIST BIOSCIENCE CORP | 1.51% |
| 12 | NATERA INC | 1.50% |
| 13 | IOVANCE BIOTHERAPEUTICS INC | 1.39% |
| 14 | ABBVIE INC | 1.37% |
| 15 | BIOGEN INC | 1.36% |
| 16 | UNITED THERAPEUTICS CORP | 1.35% |
| 17 | AMGEN INC | 1.32% |
| 18 | HALOZYME THERAPEUTICS INC | 1.28% |
| 19 | EXELIXIS INC | 1.28% |
| 20 | GILEAD SCIENCES INC | 1.27% |
| 21 | TG THERAPEUTICS INC | 1.25% |
| 22 | PROTAGONIST THERAPEUTICS INC | 1.19% |
| 23 | GRAIL INC | 1.17% |
| 24 | REGENERON PHARMACEUTICALS | 1.17% |
| 25 | VERTEX PHARMACEUTICALS INC | 1.17% |
Market data, supplied Oct 15, 2026.
Sector weights
| Healthcare | 99.28% |
| Financial Services | 0.72% |
Market data, supplied Oct 15, 2026.
Country weights
| United States | 95.79% |
| Switzerland | 1.43% |
| Ireland | 1.41% |
| United Kingdom | 1.25% |
| Netherlands | 0.45% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.